Dr. Serkan Aygin Clinic Launches 2026 Hair Restoration Protocol to Improve Graft Survival Rates

Dr. Serkan Aygin Clinic announced the formal launch of its 2026 Hair Restoration Protocol. Effective since January 1, 2026, this standardized five-stage clinical framework integrates robotic 3D diagnostics and advanced exosome signaling to address the industry-wide challenge of graft attrition.

While hair restoration demand continues to rise globally, industry averages for follicular anchor rates typically fluctuate between 75% and 95%. Following an internal multi-year audit of over 2,500 clinical cases, the Dr. Serkan Aygin Clinic reports that its refined methodology achieved graft survival rates of up to 98% in defined patient cohorts.

“Hair restoration is entering a data-driven era,” said Dr. Serkan Aygin, recipient of the Best Hair Transplant Surgery award at the European Awards in Medicine 2019. “Our 2026 protocol reflects a shift toward measurable biological outcomes rather than mere cosmetic promises. By addressing the cellular environment of the scalp before, during, and after the physical transplant, we are making high-yield results a predictable medical standard.”

A Multi-Phase News Milestone in Clinical Restoration

The 2026 Protocol marks the formal transition of the clinic toward a bio-integrated surgical model for hair transplant in Turkey. Key pillars of the rollout include:

• Integrated 3D Robotic Mapping: The standardization of ARTAS robotic imaging for all primary consultations. This German-engineered topographical system evaluates donor hair caliber and bulb depth to a microscopic degree, reducing accidental follicular transection (damage) by a reported 15% compared to manual mapping.
• Ischemic Time Reduction via DHI & Sapphire FUE: To maintain graft viability, the clinic has moved to exclusive use of Sapphire FUE and Direct Hair Implantation (DHI). This shift minimizes the "out-of-body" time for follicles, maintaining optimal physiological conditions in chilled, nutrient-rich solutions to prevent cellular death.
• Standardization of Exosome Signaling: In a significant departure from previous years, the 2026 protocol now does not only includes Exosome Therapy as a standard procedural step, but also Alloblast, SVF and Regenera Activa. In patients with compromised scalp health or thinning hair, Exosomes provide the necessary biological "instruction" to ensure that even the finest transplanted grafts reach their full potential. This is often the difference between a standard result and the dense, lush textures seen in hair transplant before and after photos from the clinic.
• Metabolic Support via LLLT: The protocol incorporates Low-Level Laser Therapy (LLLT) to stimulate mitochondria within hair cells. By increasing ATP (energy) production, the treatment helps transplanted grafts overcome "surgical shock," ensuring a faster transition into the anagen (growth) phase.
• Hair Boosters: Dr. Aygin has developed his own medical-grade line, MD Plus Bio. These are pharmaceutical formulations designed to maintain a balanced scalp ecosystem, blocking DHT locally and nourishing follicles during their maturation phase. It is this comprehensive approach that has solidified Turkey's global reputation.

Data-Driven Outcomes and Market Impact

The clinic’s disclosure of its 98% survival rate is based on internal outcome tracking conducted between 2023 and 2025. The data revealed that the integration of Exosome Therapy with DHI and Sapphire FUE reduced "surgical shock" (temporary shedding) by 22%, allowing a higher percentage of grafts to remain in the anagen (growth) phase immediately following relocation, and increasing hair regrowth by as much as 30%.

By formalizing these steps into a singular protocol, the clinic aims to provide patients with a transparent, verifiable roadmap for their hair restoration journey. This milestone signals a broader transformation within the Turkish medical landscape, moving away from high-volume industrial medicine toward a sophisticated, science-driven restoration model. By shifting the focus from the number of grafts implanted to the biological quality of the scalp environment, the clinic is addressing a critical market gap.

Furthermore, the protocol’s impact extends to the global economy of medical tourism. With Turkey projected to host over 2 million health tourists by the end of 2026, the standardization of the Aygin Protocol provides a secure investment framework for international patients who prioritize clinical evidence and long-term follicular health over low-cost alternatives. By formalizing these steps, the Dr. Serkan Aygin Clinic aims to stabilize clinical outcomes across the industry, ensuring that Turkey remains the undisputed global hub for high-yield hair restoration.

About Dr. Serkan Aygin Clinic

Founded by Dr. Serkan Aygin, a global authority with 30 years of experience and an estimated 100,000 successful procedures, the clinic serves as a center of excellence in Istanbul. Attracting patients from over 140 countries, the clinic is a pioneer in FUE Sapphire, DHI, and bio-technological hair treatments. For more information, visit www.drserkanaygin.com. 

Media Contact

Yunus Marangoz
yunus.marangoz@dokuclinic.com